Peripheral Nerve Injuries Clinical Trial
Official title:
Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle
Early ambulation after knee replacement surgery is made possible in large part by providing
safe and effective pain control. Peripheral nerve blocks are increasingly used for
postoperative analgesia since they can provide excellent pain relief and minimize the need
for opioid analgesics.
Ultrasound guided adductor canal block (ACB) was first reported in 2009 by anesthesiologists
at the University of Utah. This block is unique in that it spares motor function in the lower
extremity. Since 2009, a number of publications have described the successful use of ACB for
pain management after total knee arthroplasty (TKA), anterior cruciate ligament (ACL)
reconstruction, and other procedures of the knee. As a component of multi-modal analgesia,
ACB can provide effective postoperative pain control and facilitate early hospital discharge.
Although it is widely utilized, the ACB block can be technically difficult to perform since
it requires injection in immediate proximity to the femoral artery and vein. In patients with
a large thigh circumference, ultrasound can be challenging since the femoral vessels are
deeper and more difficult to visualize. This presents the possibility of vessel trauma and/or
intravascular injection of local anesthetic.
The investigators have implemented a new technique for performing the ACB. This block is
performed using a 20G fenestrated needle. The needle is FDA approved for peripheral nerve
block. It has an occluded tip with 8 side ports on alternating sides of the distal 2cm.
Injection through the fenestrated needle produces effective distribution of local anesthetic
to nerves of the adductor canal without immediate proximity to the femoral artery and vein.
The ultrasound landmarks used to perform ACB with the fenestrated needle are readily visible
even in patients with very large thigh circumference.
In summary, early experience with the US guided ACB block performed with a fenestrated block
needle suggests that it is technically easier and potentially safer to perform than blocks
performed with a conventional needle.
This study should be performed prospectively in order to ensure accurate data comparing the
two needles. A retrospective review of blocks performed using a conventional needle would not
provide accurate data with respect to the number of attempts, time required to perform the
blocks or the resulting sensory changes after performing the nerve block.
A new fenestrated (multiple side-ports) needle has recently been cleared by the FDA for
performing peripheral nerve blocks. Experience with this needle suggests that it can make ACB
technically easier and safer to perform.This is due in large part because it eliminates the
need to position the needle in close proximity to large blood vessels in the thigh.
The objectives for this study would be to prospectively compare nerve blocks performed for
postoperative analgesia performed using conventional (single bevel) needles to those
performed using the fenestrated needle. Specifically, the investigators would compare metrics
such as; time to perform the block, number of attempts, unintentional blood vessel puncture,
and successful injection rates. Successful injection rates would be quantified by comparing
the distribution of sensory loss after each injection. Those injections resulting in a loss
of sensation over the skin surfaces innervated by nerves of the adductor canal would be
judged to be "successful". An absence of sensory change in these surfaces would be judged as
"unsuccessful".
Procedures:
All patients will be randomized to receive treatment with one of two nerve block needles.
Neither the investigators nor the patients will be blinded. Randomization will be based
solely on the results of a computer generated random sequence.
All patients participating in the study will receive the same anesthetic, surgery,
postoperative care, and pain management that is provided currently for patients (including
those not enrolled in this study protocol) having knee replacement at the University of Utah.
This investigation is designed to compare only the efficacy of two needle designs that are
currently used and FDA approved for peripheral nerve block.
Patients consenting to participate in the study will be randomized to receive an ACB
performed with either a single bevel (conventional) or a fenestrated needle. The ACB will be
placed in the preoperative holding area approximately 30 minutes before being transported to
the operating room. During performance of the nerve block, the time to complete the nerve
block, the number of attempts used to complete the nerve block, the incidence of blood vessel
puncture and/or blood aspiration will be recorded for each case. All patients will also be
assessed for sensory changes in the lower extremity as a metric for block efficacy.
In the operating room, patients will be anesthetized using a spinal block and will receive
intravenous sedation at the discretion of the attending anesthesiologist.
During the postoperative period, the quality and duration of analgesia will be primary
metrics used to compare the two study needles. Specifically, numerical pain scores reported
by the patients and opioid consumption will be compared for both groups.
All patients for whom the is a possible "failed nerve block" will be offered a repeat
"rescue" nerve block after surgery. A failed block would be defined by an absence of sensory
changes in the extremity associated with poor pain control reported by the patient.
Additional metrics for comparison would be the time to ambulation after surgery and the time
to hospital discharge.
Statistical Methods, Data Analysis and Interpretation
The study will be prospective and randomized for two groups of patients having nerve blocks
as part of their pain management protocol for total knee replacement.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04572906 -
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
|
Phase 2 | |
Active, not recruiting |
NCT03999424 -
Autologous Human Schwann Cells in Peripheral Nerve Repair
|
Phase 1 | |
Not yet recruiting |
NCT05848778 -
Non-invasive Therapy to Drive Nerve Regeneration
|
N/A | |
Completed |
NCT02070367 -
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
|
N/A | |
Recruiting |
NCT03205124 -
The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration.
|
Phase 2/Phase 3 | |
Recruiting |
NCT01526681 -
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
|
||
Recruiting |
NCT03422107 -
Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia
|
N/A | |
Active, not recruiting |
NCT05339594 -
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
|
||
Completed |
NCT02437695 -
Robot Assisted Radical Prostatecomy and Positional Injury
|
N/A | |
Completed |
NCT01954199 -
The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain
|
N/A | |
Withdrawn |
NCT02095899 -
Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
|
Phase 2 | |
Recruiting |
NCT02403661 -
Electrical Stimulation to Enhance Peripheral Nerve Regeneration
|
N/A | |
Completed |
NCT03191032 -
Early Sensory Re-education of the Hand With a Sensor Glove Model
|
N/A | |
Recruiting |
NCT06209801 -
Mirror Therapy Integrated With Electrical Stimulation for Cortical Modulations
|
N/A | |
Recruiting |
NCT03913689 -
StimRouter Registry Clinical Protocol
|
||
Terminated |
NCT02459015 -
Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions
|
N/A | |
Recruiting |
NCT03780855 -
Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve Scaffold
|
N/A | |
Recruiting |
NCT05884125 -
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
|
N/A | |
Recruiting |
NCT04789044 -
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
|
Phase 2 | |
Recruiting |
NCT05611983 -
Experience and Feasibility of Methods for Early Sensory Training
|
N/A |